摘要
目的:探究乳腺癌根治术后应用多西紫杉醇联合卡培他滨化疗及心理干预的临床观察。方法:将前来我院就医的84例乳腺癌患者作为研究对象,随机法分入观察组、对照组各42例,患者均采取乳腺癌根治术治疗,化疗方案均为多西紫杉醇联合卡培他滨,均行常规护理,而观察组增添心理护理干预,观察两组生存率情况,记录两组干预前后心理焦虑、抑郁情况,调查两组满意度。结果:两组1年、2年生存率比较无明显差异(P>0.05);而就3年生存率而言,观察组为97.62%,对照组为85.71%,观察组更高,比较有显著差异(P<0.05);干预前,两组焦虑、抑郁评分相比无统计学差异,P>0.05;干预后两组焦虑、抑郁评分均下降,观察组降幅高于对照组,比较差异明显(P<0.05);观察组满意度高于对照组(97.62%>83.33%),比较具有显著性差异(P<0.05)。结论:在乳腺癌患者应用乳腺癌根治术后,予以患者多西紫杉醇联合卡培他滨化疗,辅以心理护理可改善患者中期生存率,减轻患者内心负面情绪,提升患者满意度。
Objective: To investigate the clinical observation of docetaxel combined with capecitabine chemotherapy and psychological intervention after radical mastectomy for breast cancer. Methods: Eighty-four patients with breast cancer were randomly divided into observation group (n=42) and control group (n=42). All patients were treated with radical mastectomy. The chemotherapy regimen was docetaxel combined with capecitabine. All patients were given routine nursing, while the observation group received psychological nursing intervention, the survival rate of the two groups were observed, the psychological anxiety and depression before and after intervention were recorded, and the satisfaction of the two groups were investigated. Results: There was no significant difference in 1-year and 2-year survival rates between the two groups (P>0.05). The 3-year survival rate was 97.62% in the observation group and 85.71% in the control group, which was higher than that in the observation group (P<0.05), but there was no significant difference in anxiety and depression scores between the two groups before intervention (P>0.05). After intervention, the scores of anxiety and depression in the two groups decreased significantly (P<0.05), and the satisfaction degree in the observation group was higher than that in the control group (97.62%>83.33%)(P<0.05). Conclusion: After radical mastectomy, the patients with breast cancer were treated with doxicervines. Huperzol combined with capecitabine chemotherapy combined with psychological nursing can improve the medium-term survival rate alleviate the negative emotions of patients and improve the satisfaction of patients.
作者
朱霞
ZHU Xia(Operating Room, Ganxi Tumor Hospital, Pingxiang City, Jiangxi Province 633700, China)
出处
《药品评价》
CAS
2019年第7期56-58,共3页
Drug Evaluation
基金
江西省卫生计生委科技计划项目(编号:20151113)
